Mouse model for protein tyrosine phosphatase D (PTPRD) associations with restless leg syndrome or willis-ekbom disease and addiction: Reduced expression alters locomotion, sleep behaviors and cocaine-conditioned place preference

Molecular Medicine

Volumn 21, Issue , 2015, Pages 717-725

  Drgonova, Jana ^a   Walther, Donna ^a   Wang, Katherine J ^a   Luke Hartstein, G ^a   Lochte, Bryson ^a   Troncoso, Juan ^b   Uetani, Noriko ^c   Iwakura, Yoichiro ^d   Uhl, George R ^a,e  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF TOKYO   (Japan)

^e VA Health Care System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

ADDICTION; ADULT; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HABITUATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; LOCOMOTION; MALE; MEMORY; MORRIS WATER MAZE TEST; MOTOR WEAKNESS; MOUSE; NONHUMAN; PHENOTYPE; PLACE PREFERENCE; PRIORITY JOURNAL; PTPRD GENE; REINFORCEMENT; RESTLESS LEGS SYNDROME; REWARD; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP; SLEEP TIME; STRENGTH; SURVIVAL RATE; WEAKNESS;

EID: 84954316984     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2015.00017     Document Type: Article

References (38)

1. Lein ES, et al. (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature. 445: 168-76.
2. Wang J, Bixby JL. (1999) Receptor tyrosine phosphatase-delta is a homophilic, neurite-promoting cell adhesion molecular for CNS neurons. Mol. Cell. Neurosci. 14: 370-84.
3. Takahashi H, et al. (2012) Selective control of inhibitory synapse development by Slitrk3-PTPdelta trans-synaptic interaction. Nat. Neurosci. 15: 389-98, S381-2.
4. Yim YS, et al. (2013) Slitrks control excitatory and inhibitory synapse formation with LAR receptor protein tyrosine phosphatases. Proc. Natl. Acad. Sci. U. S. A. 110: 4057-62.
5. Brose N. (2013) Why we need more synaptogenic cell-adhesion proteins. Proc. Natl. Acad. Sci. U. S. A. 110: 3717-8.
6. Freeman AA, Rye DB. (2013) The molecular basis of restless legs syndrome. Curr. Opin. Neurobiol. 23: 895-900.
7. Schormair B, et al. (2008) PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat. Genet. 40: 946-8.
8. Yang Q, et al. (2011) Family-based and population-based association studies validate PTPRD as a risk factor for restless legs syndrome. Mov. Disord. 26: 516-9.
9. Uhl GR, et al. (2008) Molecular genetics of successful smoking cessation: convergent genomewide association study results. Arch. Gen. Psychiatry. 65: 683-93.
10. Uhl GR, et al. (2014) Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances. Mol. Psychiatry. 19: 50-4.
11. Uhl GR, et al. (2008) "Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice. Biochem. Pharmacol. 75: 98-111.
12. Drgon T, et al. (2010) Genome wide association for addiction: replicated results and comparisons of two analytic approaches. PLoS One. 5: e8832.
13. Drgon T, et al. (2011) "Replicated" genome wide association for dependence on illegal substances: genomic regions identified by overlapping clusters of nominally positive SNPs. Am. J. Med. Genet B. Neuropsychiatr. Genet. 156: 125-38.
14. Drgon T, et al. (2009) Genome-wide association for smoking cessation success: participants in a trial with adjunctive denicotinized cigarettes. Mol. Med. 15: 268-74.
15. Johnson C, et al. (2008) Genome wide association for substance dependence: convergent results from epidemiologic and research volunteer samples. BMC Med. Genet. 9: 113.
16. Johnson C, Drgon T, Walther D, Uhl GR. (2011) Genomic regions identified by overlapping clusters of nominally-positive SNPs from genomewide studies of alcohol and illegal substance dependence. PLoS One. 6: e19210.
17. Drgon T, et al. (2009) Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers. Mol. Med. 15: 21-7.
18. Uhl GR, et al. (2010) Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement. Pharmacogenomics. 11: 357-67.
19. Uhl GR, et al. (2010) Genome-wide association for smoking cessation success in a trial of precessation nicotine replacement. Mol. Med. 16: 513-26.
20. Tzschentke TM. (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56: 613-72.
21. Thierry-Mieg D, Thierry-Mieg J. (2006) AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol. 7 Suppl 1: S12.
22. Hishimoto A, et al. (2007): Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms. Hum. Mol. Genet. 16: 2880-91.
23. Tobacco and Genetics Consortium. (2010) Genomewide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet. 42: 441-7.
24. Hebbard LW, et al. (2008) T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. Cancer Res. 68: 1407-16.
25. Uetani N, et al. (2000) Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice. EMBO J. 19: 2775-85.
26. Drgonova J, Zimonjic DB, Hall FS, Uhl GR. (2010) Effect of KEPI (Ppp1r14c) deletion on morphine analgesia and tolerance in mice of different genetic backgrounds: when a knockout is near a relevant quantitative trait locus. Neuroscience. 165: 882-95.
27. Hall FS, et al. (2012) Effects of neurotensin gene knockout in mice on the behavioral effects of cocaine. Psychopharmacology (Berl.). 219: 35-45.
28. Morris R (1984). Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods. 11: 47-60.
29. Brambilla F. (1938) Statistica metodologica e calcolo delle probabilità (a proposito di recenti studi del prof. Bonferroni). Giornale degli Economisti e Rivista di Statistica. 78 (Anno 53): 398-415.
30. Sora I, Li B, Igari M, Hall FS, Ikeda K. (2010) Transgenic mice in the study of drug addiction and the effects of psychostimulant drugs. Ann. N. Y. Acad. Sci. 1187: 218-46.
31. Pontius JU, Wagner L, Schuler GD. (2003) UniGene: a Unified View of the Transcriptome [Internet]. In: The NCBI Handbook. McEntyre J, Ostell J (eds.). (2002-) National Center for Biotechnology Information, Bethesda (MD). Available from: http://www. ncbi. nlm. nih. gov/books/NBK21101/?report=reader.
32. Hawrylycz MJ, et al. (2012) An anatomically comprehensive atlas of the adult human transcriptome. Nature. 489: 391-9.
33. Treutlein J, et al. (2009) Genome-wide association study of alcohol dependence. Arch. Gen. Psychiatry. 66: 773-84.
34. Ishiguro H, et al. (2006) NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice. Neuropsychopharmacology. 31: 572-84.
35. Jackson KJ, et al. (2010) Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice. J. Pharmacol. Exp. Ther. 334: 137-46.
36. DeAndrade MP, et al. (2012) Motor restlessness, sleep disturbances, thermal sensory alterations and elevated serum iron levels in Btbd9 mutant mice. Hum. Mol. Genet. 21: 3984-92.
37. Uhl GR, et al. (2008) Molecular genetics of addiction and related heritable phenotypes: genomewide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects. Ann. N. Y. Acad. Sci. 1141: 318-81.
38. Uhl GR, Drgonova J. (2014) Cell adhesion molecules: druggable targets for modulating the connectome and brain disorders? Neuropsychopharmacology. 39: 235.